In this paper, we explore the reasons behind the growth of cannabis as a therapeutic substance and we explore the dynamics and developments in European medical cannabis, with a particular focus on Germany, Europe’s leading cannabis market.

The global cannabis market is evolving from an illegal and mainly recreational market dominated by drug cartels to a legal medical and recreational market in the hands of public and private companies.

Western Europe boasts some of the world’s fastest-evolving and most significant opportunities in medical cannabis, with countries reassessing their restrictions as public support for legalization grows and commercial and social benefits become apparent.

Existing medical cannabis markets such as Germany, Italy and the Netherlands are expanding their programs whilst new medical markets like the UK, France and Spain are reviewing current legislation. And the seeds of a second wave of growth to allow recreational adult use of cannabis are being planted.

Western Europe is on track to become the world’s largest legal medical cannabis market over the next ten years, projected to be worth EUR15.3bn in 2029, up 60x from EUR250m in 2019. Germany, the leading European medical market, is expected to grow to EUR4.9bn by 2029 from EUR210m in 20191. In this paper, we examine the dynamics and developments in European medical cannabis, with a detailed look at the German market.

Click here to download the report >>